Literature DB >> 21888539

Microcin C: biosynthesis, mode of action, and potential as a lead in antibiotics development.

Gaston H M Vondenhoff1, Arthur Van Aerschot.   

Abstract

The natural compound Microcin C (McC) is a Trojan horse inhibitor of aspartyl tRNA synthetases endowed with strong antibacterial properties, in which a heptapeptide moiety is responsible for active transport of the inhibitory metabolite part into the bacterial cell. The intracellularly formed aspartyl AMP analogue carries a chemically more stable phosphoramidate linkage, in comparison to the labile aspartyl-adenylate, and in addition is esterified with a 3-aminopropyl moiety. Therefore, this compound can target aspartyl-tRNA synthetase. The biochemical production and secretion of McC, and the possibilities to develop new classes of antibiotics using the McC Trojan horse concept in combination with sulfamoylated adenosine analogues will be discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21888539     DOI: 10.1080/15257770.2011.583972

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

Review 1.  Biosynthesis and Chemical Synthesis of Albomycin Nucleoside Antibiotics.

Authors:  Meiyan Wang; Yuxin Zhang; Lanxin Lv; Dekun Kong; Guoqing Niu
Journal:  Antibiotics (Basel)       Date:  2022-03-24

2.  The Novel Property of Heptapeptide of Microcin C7 in Affecting the Cell Growth of Escherichia coli.

Authors:  Rensen Ran; Huan Zeng; Dong Zhao; Ruiyuan Liu; Xia Xu
Journal:  Molecules       Date:  2017-03-08       Impact factor: 4.411

3.  N-alkylated aminoacyl sulfamoyladenosines as potential inhibitors of aminoacylation reactions and microcin C analogues containing D-amino acids.

Authors:  Gaston H Vondenhoff; Ksenia Pugach; Bharat Gadakh; Laurence Carlier; Jef Rozenski; Mathy Froeyen; Konstantin Severinov; Arthur Van Aerschot
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.